<div id="readability-page-1"><p>Renaissance Capital LLC boosted its position in  Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 381.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor  owned 114,276 shares of the company's stock after purchasing an additional 90,516 shares during the period. Astera Labs accounts for about  9.9% of Renaissance Capital LLC's portfolio, making the stock its 2nd biggest holding. Renaissance Capital LLC owned about 0.07% of Astera Labs worth $15,136,000 at the end of the most recent reporting period.</p><ul><li>Hidden Gems: Uncovering 2024's Best Software Stocks</li></ul><p>A number of other hedge funds have also recently made changes to their positions in the company. Strategic Blueprint LLC lifted its holdings in  Astera Labs by 3.6% during the 3rd quarter. Strategic Blueprint LLC now owns 5,684 shares of the company's stock worth $298,000 after buying an additional 195 shares during the period.  GAMMA Investing LLC lifted its stake in shares of  Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company's stock worth $68,000 after acquiring an additional 224 shares during the period.  Geneos Wealth Management Inc. acquired a new position in shares of  Astera Labs in the fourth quarter worth approximately $36,000.  UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in  Astera Labs by 5.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company's stock valued at $277,000 after acquiring an additional 284 shares during the last quarter.  Finally, ORG Wealth Partners LLC acquired a new stake in  Astera Labs during the 4th quarter valued at approximately $42,000. 60.47% of the stock is owned by institutional investors and hedge funds. </p><h2>Astera Labs Trading Down 3.3 %</h2><p>Shares of ALAB opened at $98.12 on Tuesday. The business's fifty day moving average is $122.46 and its 200 day moving average is $80.36. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39. </p><ul><li>3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance</li></ul><p>Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs's revenue for the quarter was up 47.1% compared to the same quarter last year.  On average, equities research analysts expect that  Astera Labs, Inc. will post -0.45 EPS for the current fiscal year. </p><h2>Analyst Ratings Changes</h2><p>A number of research firms have recently commented on ALAB. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Astera Labs from $60.00 to $100.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, November 5th. Craig Hallum increased their price target on Astera Labs from $75.00 to $105.00 and gave the stock a &#34;buy&#34; rating in a report on Tuesday, November 5th. JPMorgan Chase &amp; Co. boosted their price objective on Astera Labs from $70.00 to $110.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, November 5th. Northland Securities raised Astera Labs from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $120.00 target price for the company in a research note on Tuesday, January 28th. Finally, Needham &amp; Company LLC  reiterated a &#34;buy&#34; rating and issued a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. One equities research analyst  has rated the stock with a hold rating, eleven have issued  a buy rating and one  has issued  a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of &#34;Buy&#34; and a consensus price target of $107.42.</p><ul><li>Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?</li></ul><p><b>Check Out Our Latest Analysis on ALAB</b></p><h2>Insider Buying and Selling</h2><p>In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares in the company, valued at approximately $53,681,402.50. This trade represents a 2.35 % decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, insider Sanjay Gajendra sold 740,000 shares of Astera Labs stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the transaction, the insider now directly owns 775,000 shares in the company, valued at $74,857,250. This represents a 48.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,690,452 shares of company stock worth $167,581,256 in the last quarter. </p><h2>About Astera Labs</h2> (Free Report)<p>Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Astera Labs</li><li>High Flyers: 3 Natural Gas Stocks for March 2022</li><li>How to Invest in Small Cap Stocks</li><li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li><li>These Are the Dividend Stocks Insiders Bought in January</li><li>Golden Cross Stocks: Pattern, Examples and Charts </li><li>How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Astera Labs Right Now?</h2><p>Before you consider Astera Labs, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.</p><p>While Astera Labs currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ALAB

<p>Renaissance Capital LLC increased its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 381% in Q4, owning 114,276 shares after acquiring 90,516 additional shares. Astera Labs constitutes 9.9% of Renaissance's portfolio, valued at $15.1 million. Other hedge funds also adjusted their positions. Astera Labs shares opened at $98.12, down 3.3%. The company reported Q3 earnings of $0.23 per share, exceeding estimates. Analysts have raised price targets, with a consensus rating of "Buy" and an average target of $107.42.</p>

Renaissance Capital LLC Raises Stock Holdings in Astera Labs, Inc. (NASDAQ:ALAB)